Can bone turnover markers help to define the suitability and duration of bisphosphonate drug holidays?
Background: On stopping bisphosphonate treatment, bone resorption may increase before evidence of a decrease in bone density. Offset of bisphosphonate effect may therefore be monitored by measuring C-terminal telopeptide (CTX) following long-term bisphosphonate treatment to inform clinical decisions...
Saved in:
Main Authors: | Louise Statham (Author), Sharon Abdy (Author), Terry J Aspray (Author) |
---|---|
Format: | Book |
Published: |
BioExcel Publishing Ltd,
2020-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bisphosphonate drug holidays: Can we recommend currently?
by: Vishal R Tandon, et al.
Published: (2014) -
Evaluation of fracture risk and potential drug holidays for postmenopausal women on long-term bisphosphonate therapy
by: Kostoff MD, et al.
Published: (2014) -
Duration and timing of bisphosphonate treatment as factors determining osteoblast mineralization
by: Somying Patntirapong
Published: (2022) -
Sclerostin as a novel marker of bone turnover in athletes
by: A Zagrodna, et al.
Published: (2016) -
Effects of Alendronate and Raloxifene on Bone Density and Bone Turnover Markers in Postmenopausal Women
by: Ebru Zülfikaroğlu, et al.
Published: (2011)